DTR Share Price Performance
CA$0.29
-0.15 (-33.33%)
Price CA$0.29
Share Pricen/a
DiagnosTear Technologies Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
DTR Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
DiagnosTear Technologies Inc. Key Details
About DTR
- Founded
- 2023
- Employees
- n/a
- CEO
- WebsiteView website
DiagnosTear Technologies Inc., an ophthalmic company, develops and commercializes disruptive diagnostic solutions for eye diseases. It engages in the development of TeaRx Dry Eye, a CE-IVD approved test based on the TeaRx platform for the identification and monitoring of dry eye syndrome; TeaRx Red Eye for differential assessment of adenoviral conjunctivitis, herpetic keratitis, and allergic conjunctivitis; and TeaRx Tear Collector, a non-invasive collector of one microliter of tear fluid and subsequent dilution in assay buffer for downstream analytical testing. The company was formerly known as Oceanview Technologies Inc. and changed its name to DiagnosTear Technologies Inc. DiagnosTear Technologies Inc. was incorporated in 2023 and is based in Vancouver, Canada.
